Published in J Virol on December 01, 1998
Targeting early infection to prevent HIV-1 mucosal transmission. Nature (2010) 5.05
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med (2009) 4.79
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Med (2005) 1.85
High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection. J Virol (2009) 1.82
Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol (2001) 1.75
Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J Virol (2007) 1.37
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques. PLoS One (2011) 1.35
Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol (2003) 1.28
Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol (2001) 1.24
Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. J Virol (2006) 1.15
Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J Virol (2002) 1.15
Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob Agents Chemother (2000) 1.12
Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis (2004) 1.11
Immunology of pediatric HIV infection. Immunol Rev (2013) 1.02
Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure. Virology (2007) 0.99
HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection? PLoS Pathog (2008) 0.94
Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef. J Virol (2001) 0.93
Mucosal T-cell responses to HIV: responding at the front lines. J Intern Med (2009) 0.90
Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus. PLoS One (2010) 0.86
Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses. J Virol (2015) 0.84
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication. J Virol (2002) 0.82
Cellular superspreaders: an epidemiological perspective on HIV infection inside the body. PLoS Pathog (2014) 0.81
Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine. Virology (2008) 0.79
Differential selection of specific human immunodeficiency virus type 1/JC499 variants after mucosal and parenteral inoculation of chimpanzees. J Virol (2002) 0.78
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. Clin Vaccine Immunol (2009) 0.77
Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge. PLoS One (2015) 0.77
Absence of reproducibly detectable low-level HIV viremia in highly exposed seronegative men and women. AIDS (2011) 0.77
Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats. Retrovirology (2010) 0.77
A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds. AIDS Res Hum Retroviruses (2015) 0.75
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med (1995) 8.23
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med (1995) 5.69
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med (1995) 5.22
Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med (1989) 4.20
Long-term HIV-1 infection without immunologic progression. AIDS (1994) 3.41
Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J Gen Virol (1987) 3.18
Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol (1994) 3.05
Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol (1997) 2.59
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol (1994) 2.23
Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr (1990) 2.15
Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J Clin Microbiol (1991) 2.08
Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J Med Primatol (1989) 1.88
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol (1995) 1.73
Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J Virol (1995) 1.56
Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology (1995) 1.55
Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol (1995) 1.52
Absence of detectable antibody in a patient infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.48
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res Hum Retroviruses (1998) 1.46
Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection--evidence for highly susceptible human hosts. J Infect Dis (1997) 1.44
Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science (1998) 1.43
Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J Med Primatol (1993) 1.37
T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS (1994) 1.32
Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques. J Immunol (1992) 1.27
Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J Virol (1996) 1.24
Unrecognized human immunodeficiency virus infection in the elderly. Arch Intern Med (1995) 1.24
Detection of measles virus RNA in urine specimens from vaccine recipients. J Clin Microbiol (1995) 1.19
Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol (1997) 1.17
The nef gene of simian immunodeficiency virus SIVmac1A11. J Virol (1992) 1.11
Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J Virol (1997) 1.11
Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol Lett (1996) 1.07
Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J Clin Microbiol (1992) 1.06
Human immunodeficiency virus infection and AIDS in a person with negative serology. J Infect Dis (1997) 1.03
Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol (1992) 1.01
Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J Med Primatol (1994) 0.98
Silent HIV infections. N Engl J Med (1989) 0.98
Reactivation of HIV type 1 in chronically infected chimpanzees following xenostimulation with human cells or with pulses of corticosteroid. AIDS Res Hum Retroviruses (1997) 0.89
Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method. J Acquir Immune Defic Syndr (1994) 0.89
Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. J Gen Virol (1995) 0.88
Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population. Blood (1992) 0.86
Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology (1991) 0.85
In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology (1998) 0.85
Regression of feline immunodeficiency virus infection. AIDS Res Hum Retroviruses (1997) 0.80
Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals. Clin Infect Dis (1995) 0.77
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
Protein interaction mapping in C. elegans using proteins involved in vulval development. Science (2000) 11.61
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet (2001) 5.67
Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med (1996) 5.63
Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas. Nature (1982) 5.23
Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses. J Exp Med (1980) 5.05
Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol (2000) 4.87
Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS (1988) 4.85
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell (2001) 4.38
Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med (1995) 4.03
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol (2000) 3.88
Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci U S A (1998) 3.88
A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest (1999) 3.86
Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J Virol (2000) 3.74
The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA (1988) 3.73
The acquisition of herpes simplex virus during pregnancy. N Engl J Med (1997) 3.73
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60
A STUDY OF THREE HUNDRED FORTY-THREE SURGICAL CASES OF INTESTINAL OBSTRUCTION. Ann Surg (1929) 3.57
Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med (1992) 3.56
Parallel neural networks for learning sequential procedures. Trends Neurosci (1999) 3.35
The Caenorhabditis elegans locus lin-15, a negative regulator of a tyrosine kinase signaling pathway, encodes two different proteins. Genetics (1994) 3.09
Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature (2001) 3.07
Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol (1994) 3.05
History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst (1993) 2.92
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol (1993) 2.92
Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature (1995) 2.79
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med (1987) 2.74
Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem (1998) 2.67
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62
Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol (1997) 2.59
Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis. South Med J (1968) 2.58
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation. Neuroreport (2000) 2.49
Regulation of Hsp70 function by a eukaryotic DnaJ homolog. J Biol Chem (1992) 2.46
Primary acute simian immunodeficiency virus infection of intestinal lymphoid tissue is associated with gastrointestinal dysfunction. J Infect Dis (1994) 2.41
Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am J Neuroradiol (2000) 2.41
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Activation of posterior gap gene expression in the Drosophila blastoderm. Nature (1995) 2.30
Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J Virol (1985) 2.29
CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucleic Acids Res (1999) 2.27
Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J Virol (1993) 2.26
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol (1994) 2.23
Zim1, a maternally expressed mouse Kruppel-type zinc-finger gene located in proximal chromosome 7. Hum Mol Genet (1999) 2.20
Response of toxigenic Vibrio cholerae 01 to physico-chemical stresses in aquatic environments. J Hyg (Lond) (1984) 2.12
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J (1996) 2.12
The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis (1990) 2.00
Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses (1998) 1.99
Status of the association of mink cell focus-forming viruses with leukemogenesis. Cold Spring Harb Symp Quant Biol (1980) 1.96
Y chromosome haplotypes reveal prehistorical migrations to the Himalayas. Hum Genet (2000) 1.95
The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res (1996) 1.94
Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science (1994) 1.94
ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer (2007) 1.94
Immunophenotypic characterization of simian immunodeficiency virus-infected dendritic cells in cervix, vagina, and draining lymph nodes of rhesus monkeys. Lab Invest (1998) 1.93
Tracking micrometastasis to multiple organs with lacZ-tagged CWR22R prostate carcinoma cells. J Histochem Cytochem (2000) 1.93
Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92
An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol Cell Biol (1995) 1.92
MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport (1998) 1.89
Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery (2001) 1.87
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J Virol (1990) 1.86
Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J Neurosurg (2001) 1.86
RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell (1999) 1.85
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev (1997) 1.85
AsMamDB: an alternative splice database of mammals. Nucleic Acids Res (2001) 1.85
Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology (1997) 1.83
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
A non-epistatic interaction of agouti and extension in the fox, Vulpes vulpes. Nat Genet (1997) 1.81
Coronavirus protein processing and RNA synthesis is inhibited by the cysteine proteinase inhibitor E64d. Virology (1995) 1.80
Identification and characterization of a serine-like proteinase of the murine coronavirus MHV-A59. J Virol (1995) 1.76
Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol (2001) 1.75
Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer (2010) 1.74
Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours. Br J Cancer (2008) 1.74
A functional protein pore with a "retro" transmembrane domain. Protein Sci (1999) 1.73
Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis (1998) 1.71
Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses (2001) 1.69
PROC c.574_576del polymorphism: a common genetic risk factor for venous thrombosis in the Chinese population. J Thromb Haemost (2012) 1.69
Cell-surface antigens associated with recombinant mink cell focus-inducing murine leukemia viruses. J Exp Med (1979) 1.69
Brain and spinal cord haemorrhages associated with Angiostrongylus vasorum infection in four dogs. Vet Rec (2006) 1.67
Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology (1993) 1.67
Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1994) 1.66
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
Host range of mink cell focus-inducing viruses. Virology (1985) 1.65
Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology (1991) 1.65
Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nat Med (1998) 1.64
Rhesus macaques that become systemically infected with pathogenic SHIV 89.6-PD after intravenous, rectal, or vaginal inoculation and fail to make an antiviral antibody response rapidly develop AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.64
Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses. J Exp Med (1981) 1.62